A total of 27 articles were identified in PubMed addressing the correlation between CHI3L1 and other biomarkers found in the CSF or serum of MS patients within the last 10 years (date of PubMed search, Table 2). This evidence concerns the gene CHI3L1 and myeloid sarcoma.